Stem cell therapy represents a shift in paradigm in our approach to treating many illnesses and conditions…
Jakarta (ANTARA) - The stem cell technology developed by Cipto Mangunkusumo Hospital (RSCM) is in line with Indonesia's health transformation agenda, particularly the third pillar on pharmaceutical and medical device resilience, the Food and Drug Supervisory Authority (BPOM) said.

"(It states) that all biotechnology and medical technology developments are to be pursued in Indonesia. It's not merely about having it (for the sake of having it), but we will truly implement it to improve referral health services," acting head of BPOM, Rizka Andalucia, said.

At a press conference here on Thursday, she informed that the tech could help with some therapies, hence her administration has granted the good medication manufacturing (CPOB) certificate to RSCM to ensure that the product's quality is good.

This will allow the technology to be implemented in other hospitals, thereby providing greater access to treatment to people who need it, she added.

Meanwhile, president director of Cipto Mangunkusumo Hospital, Supriyanto Dharmoredjo, said that more than 1,700 patients at his hospital have undergone the stem cell therapy. The therapy has been used to treat broken bones, diabetes mellitus type 2, herniated disk, and burn scars, among other things, he informed.

"Stem cell therapy represents a shift in paradigm in our approach to treating many illnesses and conditions, from chronic illness to acute injuries, by tapping into the power of stem cell regeneration," Dharmoredjo explained.

According to him, the innovation has great potential as it can lead to a brighter future for the medical world.

The therapy has been developed through collaboration between the hospital, University of Indonesia, and Kimia Farma, he added.

With the certification, it is expected that the production can meet the required quality and accuracy so that the stem cell technology can become a definitive standard of therapy, he said.

Related news: BRIN, ASPI to support stem cell research in Indonesia
Related news: BRIN encourages stem cell research in Indonesia
Related news: Ministry conducts clinical trial for stem cells to treat COVID-19





Reporter: Mecca Yumna Ning Prisie
Editor: Azis Kurmala
Copyright © ANTARA 2024